HistoIndex’s Second Harmonic Generation (SHG) Technology: A Potentially Important Tool Used In Madrigal’s Phase 2 Nonalcoholic Steatohepatitis (NASH) Clinical Trial
HistoIndex’s Second Harmonic Generation (SHG) Technology: A Potentially Important Tool Used In Madrigal’s Phase 2 Nonalcoholic Steatohepatitis (NASH) Clinical Trial SINGAPORE, Dec. 23, 2018 – HistoIndex’s AI-based SHG technology has the potential to yield important results from NASH clinical trials. HistoIndex’s SHG technology was featured in Madrigal Pharmaceuticals’ Presidential Plenary presentation during AASLD’s The Liver Meeting® 2018, for its presentation …